Supplemental Figure 2. Expression levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsamiR-146a-5p in plasma from patients with progressive HIV disease and without ART.
Twenty new samples were recruited and analyzed by qPCR (individual qPCR assays). miR-23a was analyzed as internal reference gene. A) As control, the samples the healthy donors were reanalyzed. As shown the repeated analysis correlated well with the previous analysis. B-D) Scatterplots showing normalized miRNA expression levels in healthy donors compared to untreated HIV samples. Non-paramteric t-tests (Mann Whitney U) were used for differential expression analysis.
Supplemental Figure 3. Transfection efficiency of CD4 T-cells with microRNA mimics.
Tcells were either mock transfected using nucleofection or transfected with 150 nM Cy-3 labelled miRNA mimic to asses transfection efficiency.
Supplemental Figure 4. Power Calculations for multiplex screening of circulating microRNAs.
A) The distribution of standard deviations obtained from 175 miRNAs across 24 samples was analyzed. The median standard deviation was 1.67. B) Using Statmate 2.0, size effects (Ct-Values differences between group means) for a given significance level of α=0.05 were calculated depending on the power (control of type-II error) and sample size. C) Tabular information underlying the plot in B) 
